Mesoblast (MESO) EBIT Margin (2015 - 2023)
Mesoblast (MESO) recorded EBIT Margin of 214.92% in the year ended Jun 30, 2026, down 286.21 percentage points from 501.13% a year earlier.
Powered by 
Analysis
Mesoblast (MESO) EBIT Margin (2015 - 2023) Analysis & Trends
Starting with the year ended Jun 30, 2015, Mesoblast's EBIT Margin history includes 12 years.
- Annual EBIT Margin has a five-year change of +1699.23 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 is the lowest annual EBIT Margin since the year ended Jun 30, 2022.
- Per Business Quant data, MESO's EBIT Margin was 501.13% in the year ended Jun 30, 2025 (-695.04 pp), 1196.17% in the year ended Jun 30, 2024 (+25.70 pp), 1170.47% in the year ended Jun 30, 2023 (+2236.71 pp) and -1066.24% in the year ended Jun 30, 2022 (+418.07 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Mesoblast | 1.90 Bn | 1.46 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -2,699.91% |
| Mar 31, 2023 | -1,218.67% |
| Dec 31, 2022 | -1,440.72% |
| Sep 30, 2022 | -1,426.21% |
| Jun 30, 2022 | -2,326.03% |
| Mar 31, 2022 | -1,255.99% |
| Dec 31, 2021 | -1,317.88% |
| Sep 30, 2021 | -733.64% |
| Jun 30, 2021 | -1,299.85% |
| Mar 31, 2021 | -1,558.22% |
| Dec 31, 2020 | -1,190.54% |
| Sep 30, 2020 | -2,159.16% |
| Jun 30, 2020 | -5,729.24% |
| Mar 31, 2020 | -169.10% |
| Dec 31, 2019 | -1,332.50% |
| Sep 30, 2019 | -63.78% |
| Jun 30, 2019 | -1,389.17% |
| Mar 31, 2019 | -2,397.36% |
| Dec 31, 2018 | -1,601.87% |
| Sep 30, 2018 | -196.46% |
API Access
Mesoblast EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();